JULIE SNYDER: Open Payments
NPI 1942872940 · ATLANTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$599 in 28 payments from 18 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $599
Food & beverage: $599
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 4 | $100 |
| Daiichi Sankyo Inc. | 4 | $83 |
| Novartis Pharmaceuticals Corporation | 3 | $74 |
| Merck Sharp & Dohme LLC | 2 | $37 |
| PFIZER INC. | 2 | $33 |
| Eisai Inc. | 1 | $30 |
| Exelixis Inc. | 1 | $30 |
| Lilly USA, LLC | 1 | $27 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $23 |
| GENZYME CORPORATION | 1 | $23 |
Products named: TECVAYLI, Enhertu, Fabhalta, KEYTRUDA, INJECTAFER, ELREXFIO, Lenvima, CABOMETYX.
Industry payments across GA — which companies pay providers there.
